Genus plc (LON:GNS)
London · Delayed Price · Currency is GBP · Price in GBX 2,278.00
+6.00 (0.26%)
May 13, 2026, 3:35 PM GMT
Genus Market Cap
Genus has a market cap or net worth of 1.52 billion as of May 13, 2026. Its market cap has increased by 45.92% in one year.
Market Cap
1.52B
Enterprise Value
1.74B
Revenue
672.00M
Ranking
n/a
PE Ratio
32.07
Stock Price
2,278.00
Market Cap Chart
Since January 30, 1998, Genus's market cap has increased from 31.03M to 1.52B, an increase of 4,799.30%. That is a compound annual growth rate of 14.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 1.52B | -12.45% |
| Dec 31, 2025 | 1.74B | 70.54% |
| Dec 31, 2024 | 1.02B | -28.43% |
| Dec 29, 2023 | 1.42B | -27.10% |
| Dec 30, 2022 | 1.95B | -39.35% |
| Dec 31, 2021 | 3.22B | 18.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oxford Nanopore Technologies | 1.09B |
| Oxford Biomedica | 784.77M |
| Avacta Group | 373.95M |
| PureTech Health | 309.63M |
| Scancell Holdings | 176.42M |
| Bioventix | 88.82M |
| Faron Pharmaceuticals Oy | 83.80M |
| Ondine Biomedical | 72.74M |